Skip to content

About us

eCounsel group

A boutique firm with unparalleled expertise in business and technology. We have good command of industrial ecology and legal practice, and have undertaken highly regarded cases. Because the small business scope, we pay more emphasis on effectiveness and efficiency, and choose clients with deliberation. The managing partner not only has extensive experiences in various legal issues more over than 20 years, but invests and manages several technology companies. In addition, he always checks each case rigorously. Clients’ business objectives are our primary focus. To achieve the same in the most cost-effective fashion trumps all seemingly sophisticated legal discussions.

The Value of Legitimately Streaming Music

2014 - 11 - 07

The CD sales had declined drastically in 21st century, we really can’t blame it to music streaming services after iPod, MP3 player, CD ripping and pirated music both on the Internet and in the night markets.


進入21世紀之後,CD銷量早已鉅幅下滑,出現iPod, MP3 player以及CD ripping以及線上和夜市賣盜版音樂光碟這種事情應該怪不到串流音樂業者吧?

還記得當時兩家P2P業者Kuro和ezPeer?2004年KKBOX問世之前,那兩家公司一毛錢都沒付給任何音樂人,專幹百分百的海盜。國外呢,也早在Spotify和Pandora等出現前就有一堆超狠的P2P,從Napster到eDonkey和BT等等,都別說音樂了,連電影和其他侵權內容都一次掃光,哪個權利人有因此而得到任何對價?

現在合法的數位音樂平台已經成為主流媒體之一,任何音樂人都有權選擇自己作品呈現與散布的方式。有的人可以只透過Youtube去發行MV,有的人可以只上Spotify等串流服務,有的人也選擇只出實體CD。至於哪種容易被盜版,如何才能賺到更多的錢,本來就是音樂人自己的生意經。

再來算算數學。什麼吻別之類的一百二百萬張這種東西是上世紀的事,不要再拿出來講笑話。現在即便是天王級的,真實銷售能上得了十萬,香檳都不知道要開多少瓶了。如果我們說市場上平均每位藝人的專輯都能賣到三萬張,每張市價$350,一張流行音樂CD的市場末端產值也不過就是一千零五十萬,一年如果總共有一百張CD也才不過十億零五千萬的市場,全部的音樂相關權利人能分到的錢加總至多也不過六成左右,通路行銷和物流費用至少吃掉四成。大家如果知道光是台灣的串流音樂,現在一年能給出多少權利金,就會看到串流平台是否真的有為音樂人創造價值。

Recommended article 

Music Streaming Services vs. Copyright Holders

PUNCHLINE is a aspiring new media in Taiwan. But every time when it weighs in on digital media, its arguments can barely scratch the surface of the reality. Continue reading

The Core Problem of Taiwan's National Health Insurance

Our health insurance is a public insurance. It should not operate like a private one. The reimbursements should only cover generic drugs not brand-name drugs. 新聞眼/加錢可選原廠藥 醫療階級化 「……國人就醫用藥將有重大變革。衛福部指示健保署試辦「藥品差額負擔試辦計畫」,明年一月一日起,比照人工水晶體、心血管支架等醫材,針對部分健保未給付的原廠藥,以學名藥價給付,民眾若負擔價差,就能使用原廠藥…」 「……民眾對於藥品常處於資訊弱勢,差額負擔會讓民眾誤以為藥品療效有差異;若是必要使用的藥品,就應健保給付,何必要民眾自行負擔?若訂定差額負擔,民眾就醫會被依財力來分等級,甚至可能引發醫院誘導患者選擇自費藥品,恐造成有錢買生,沒錢買死…」 http://ppt.cc/z90o8 綜觀本篇新聞報導內容,撰稿者顯未探究健保作為「社會保險」的本質為何。 對於政府的作為,我很少表達肯定。對於我自己、對我自己所創立的各個事業,更是這樣。不自我鞭策,哪來的進步? 但衛福部的這一步,我則認為,是終於找到正確的方向了。 我在四年前受亞洲藥學會 (FAPA) 的邀請,在第一屆學名藥研討會中發表了…

The E-commerce Organised Crime

The Taiwanese authority recently cracked down a group of 5 people who allegedly sell imported Chinese counterfeits (luxury clothings, accessories, etc.) to over a thousand Taiwanese buyers on several e-commerce platforms in Taiwan. This isn’t something…